Drugs / DRL-17822
last change Jun 2012 re-read 3 minutes ago

DRL-17822

Developed for
hyperlipidemia
Investigated by
Dr. Reddy's Laboratories Limited · PharmaNet

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01388816 Jul 2011 → May 2012 hyperlipidemia Dr. Reddy's Laboratories Limited Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DRL-17822 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01388816 ↗